INCY
What one share of Incyte holds
Services – Commercial Physical and Biological Research
Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. Our global headquarters is located in Wilmington, Delaware, where we conduct discovery, clinical development and commercial operations.
Incyte’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $26.43 |
|---|---|
| Profit | $7.06 |
| Cash and investments | $17.31 |
| Book value | $28.12 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $5.70 | $0.54 | $0.62 | $0.95 | — | $2.22 |
| 2017 | $7.51 | −$1.53 | $0.54 | −$1.00 | — | $7.72 |
| 2018 | $8.73 | $0.51 | $0.34 | $1.22 | — | $9.03 |
| 2019 | $9.92 | $2.05 | $0.36 | $2.91 | — | $12.02 |
| 2020 | $12.23 | −$1.36 | $0.86 | −$1.43 | — | $11.90 |
| 2021 | $13.45 | $4.27 | $0.82 | $2.56 | — | $17.05 |
| 2022 | $15.16 | $1.52 | $0.35 | $3.98 | — | $19.62 |
| 2023 | $16.36 | $2.65 | — | $2.20 | — | $23.14 |
| 2024 | $20.15 | $0.15 | — | $1.59 | — | $17.82 |
| 2025 | $25.62 | $6.41 | — | $7.04 | — | $26.04 |